The DOI matches its Crossref record; 45 of the 45 references it cites were found in a registry or an index.
Physiologically based pharmacokinetic modelling 2: Predicting the tissue distribution of acids, very weak bases, neutrals and zwitterions
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Physiological Parameters in Laboratory Animals and Humans
Davies, B., & Morris, T. (1993) · Pharmaceutical Research · doi:10.1023/a:1018943613122 · Cited by 2,926
Clinical pharmacokinetics; concepts and applications
(1989) · General Pharmacology: The Vascular System · doi:10.1016/0306-3623(89)90348-0 · Cited by 2,223
Applied pharmacokinetics : principles of therapeutic drug monitoring
Evans, W. E., Schentag, J. J., & Jusko, W. J. (1992) · Medical Entomology and Zoology · Cited by 1,044
Rodgers, T., Leahy, D., & Rowland, M. (2005) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.20322 · Cited by 776
Self-citationPoulin, P., & Theil, F. (2002) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.10005 · Cited by 568
Poulin, P., & Theil, F. (2000) · Journal of Pharmaceutical Sciences · doi:10.1002/(sici)1520-6017(200001)89:1<16::aid-jps3>3.0.co;2-e · Cited by 424
Role of transport proteins in drug absorption, distribution and excretion
Ayrton, A., & Morgan, P. (2001) · Xenobiotica · doi:10.1080/00498250110060969 · Cited by 421
Plasma and Tissue Protein Binding of Drugs in Pharmacokinetics
Jusko, W. J., & Gretch, M. (1976) · Drug Metabolism Reviews · doi:10.3109/03602537608995839 · Cited by 372
Poulin, P., & Theil, F.-P. (2002) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.10128 · Cited by 303
Berezhkovskiy, L. M. (2004) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.20073 · Cited by 296
Research works printed but not linked: 18
- Chen, 2004, Studies of phenytoin binding to human serum albumin by high-performance affinity chromatography, J Chromatogr B, 809, 137, 10.1016/j.jchromb.2004.06.012 · doi:10.1016/j.jchromb.2004.06.012
- Aubry, 1995, Comparison of drug binding interactions on human, rat and rabbit serum albumin using high-performance displacement chromatography, Comp Biochem Physiol, 112C, 257
- Rahman, 1993, Studies of interaction of caprofen and its enantiomers with albumin I: mechanism of binding studied by dialysis and spectroscopic methods, Biochem Pharmacol, 46, 1721, 10.1016/0006-2952(93)90576-I · doi:10.1016/0006-2952(93)90576-i
- Bjorkman, 1996, Determination of the steady state distribution of midazolam in the rat, J Pharm Sci, 85, 887, 10.1021/js960113+ · doi:10.1021/js960113+
- Lee, 1988, Kinetics and mechanisms of etodolac degradation in aqueous solutions, J Pharm Sci, 77, 81, 10.1002/jps.2600770116 · doi:10.1002/jps.2600770116
- Brooks, 1990, The pharmacokinetics of etodolac enantiomers in the rat: lack of pharmacokinetic interaction between enantiomers, Drug Metab Dispos, 18, 471
- Chatton, 1990, Salictclic acid permeability properties of the rabbit cortical collecting duct, Am J Physiol, 259, F613
- Yoshikawa, 1984, Effect of pregnancy on tissue distribution of salicylate in rats, J Pharm Sci, 12, 500
- Kwon, 1987, Physiological pharmacokinetic model for the distribution and elimination of tenoxicam, Int J Pharmaceut, 37, 219, 10.1016/0378-5173(87)90032-9 · doi:10.1016/0378-5173(87)90032-9
- Kessel, 2001, Continuum solvent model studies of the interactions of an anticonvulsant drug with a lipid bilayer, Biophys J, 80, 2536, 10.1016/S0006-3495(01)76225-X · doi:10.1016/s0006-3495(01)76225-x
- Naber, 2003, Antibiotic therapy-rationale and evidence for optimal drug concentrations in prostatic and seminal fluid and in prostatic tissue, Andrologia, 35, 331, 10.1111/j.1439-0272.2003.tb00868.x · doi:10.1111/j.1439-0272.2003.tb00868.x
- Brooks, 1991, Enantioselective pharmacokinetics of etodolac in the rat: tissue distribution, tissue binding and in vitro metabolism, J Pharm Sci, 80, 1058, 10.1002/jps.2600801112 · doi:10.1002/jps.2600801112
- Yoshikawa, 1984, Effect of pregnancy on tissue distribution of salicylate in rats, Drug Metab Dispos, 12, 500
- Funakoshi, 2005, Role of organic anion transporting polypeptide 2 in pharmacokinetics of digoxin and -methyldigoxin in rats, J Pharm Sci, 94, 1196, 10.1002/jps.20346 · doi:10.1002/jps.20346
- Olanoff, 1979, Controlled release of tetracycline II: development of an in vivo flow-limited pharmacokinetic model, J Pharm Sci, 68, 1151, 10.1002/jps.2600680925 · doi:10.1002/jps.2600680925
- Yu, 1995, Analysis of tissue distribution of valproate in guinea-pigs: evidence for its capacity limited distribution, Pharm Res, 12, 421, 10.1023/A:1016264821127 · doi:10.1023/a:1016264821127
- Olanoff, 1980, Controlled release of tetracycline III: a physiological pharmacokinetic model of the pregnant rat, J Pharmacokin Biopharm, 8, 599, 10.1007/BF01060056 · doi:10.1007/bf01060056
- Funakoshi, 2003, Role of P-glycoprotein in pharmacokinetics and drug interactions of digoxin and -methyldigoxin in rats, J Pharm Sci, 92, 1455, 10.1002/jps.10416 · doi:10.1002/jps.10416
Cited by
Physiologically-Based Pharmacokinetics in Drug Development and Regulatory Science
Rowland, M., Peck, C., & Tucker, G. (2011) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-010510-100540 · Cited by 662
Self-citationCoexistence of passive and carrier-mediated processes in drug transport
Sugano, K., Kansy, M., Artursson, P., Avdeef, A., Bendels, S., Di, L., Ecker, G. F., Faller, B., Fischer, H., Gerebtzoff, G., et al. (2010) · Nature Reviews Drug Discovery · doi:10.1038/nrd3187 · Cited by 649
The Simcyp ® Population-based ADME Simulator
Jamei, M., Marciniak, S., Feng, K., Barnett, A., Tucker, G., & Rostami-Hodjegan, A. (2009) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1517/17425250802691074 · Cited by 533
Root Uptake of Pharmaceuticals and Personal Care Product Ingredients
Miller, E. L., Nason, S. L., Karthikeyan, K. G., & Pedersen, J. A. (2016) · Environmental Science & Technology · doi:10.1021/acs.est.5b01546 · Cited by 524
Zhao, P., Zhang, L., Grillo, J. A., Liu, Q., Bullock, J. M., Moon, Y. J., Song, P., Brar, S. S., Madabushi, R., Wu, T. C., et al. (2011) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2010.298 · Cited by 522
Sager, J. E., Yu, J., Ragueneau-Majlessi, I., & Isoherranen, N. (2015) · Drug Metabolism and Disposition · doi:10.1124/dmd.115.065920 · Cited by 518
Applied Concepts in PBPK Modeling: How to Build a PBPK/PD Model
Kuepfer, L., Niederalt, C., Wendl, T., Schlender, J., Willmann, S., Lippert, J., Block, M., Eissing, T., & Teutonico, D. (2016) · CPT: Pharmacometrics & Systems Pharmacology · doi:10.1002/psp4.12134 · Cited by 425
Mechanistic Approaches to Volume of Distribution Predictions: Understanding the Processes
Rodgers, T., & Rowland, M. (2007) · Pharmaceutical Research · doi:10.1007/s11095-006-9210-3 · Cited by 420
Self-citationJamei, M., Dickinson, G. L., & Rostami-Hodjegan, A. (2009) · Drug Metabolism and Pharmacokinetics · doi:10.2133/dmpk.24.53 · Cited by 368
General approach for the calculation of tissue to plasma partition coefficients
Schmitt, W. (2008) · Toxicology in Vitro · doi:10.1016/j.tiv.2007.09.010 · Cited by 349
PBPK models for the prediction of in vivo performance of oral dosage forms
Kostewicz, E. S., Aarons, L., Bergstrand, M., Bolger, M. B., Galetin, A., Hatley, O., Jamei, M., Lloyd, R., Pepin, X., Rostami-Hodjegan, A., et al. (2014) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2013.09.008 · Cited by 315
Applications of Polyparameter Linear Free Energy Relationships in Environmental Chemistry
Endo, S., & Goss, K.-U. (2014) · Environmental Science & Technology · doi:10.1021/es503369t · Cited by 302
Xue, C., Zhang, X., & Cai, W. (2017) · Pharmaceutics · doi:10.3390/pharmaceutics10010001 · Cited by 291
Capacities of Membrane Lipids to Accumulate Neutral Organic Chemicals
Endo, S., Escher, B. I., & Goss, K.-U. (2011) · Environmental Science & Technology · doi:10.1021/es200855w · Cited by 289
Thomas, R. S., Philbert, M. A., Auerbach, S. S., Wetmore, B. A., Devito, M. J., Cote, I., Rowlands, J. C., Whelan, M. P., Hays, S. M., Andersen, M. E., et al. (2013) · Toxicological Sciences · doi:10.1093/toxsci/kft178 · Cited by 272
De Buck, S. S., Sinha, V. K., Fenu, L. A., Nijsen, M. J., Mackie, C. E., & Gilissen, R. A. H. J. (2007) · Drug Metabolism and Disposition · doi:10.1124/dmd.107.015644 · Cited by 256
Jamei, M. (2016) · Current Pharmacology Reports · doi:10.1007/s40495-016-0059-9 · Cited by 244
Eissing, T. (2011) · Frontiers in Physiology · doi:10.3389/fphys.2011.00004 · Cited by 204
PBPK modelling of inter-individual variability in the pharmacokinetics of environmental chemicals
Bois, F. Y., Jamei, M., & Clewell, H. J. (2010) · Toxicology · doi:10.1016/j.tox.2010.06.007 · Cited by 194
Miller, N. A., Reddy, M. B., Heikkinen, A. T., Lukacova, V., & Parrott, N. (2019) · Clinical Pharmacokinetics · doi:10.1007/s40262-019-00741-9 · Cited by 142
Thelen, K., Coboeken, K., Willmann, S., Burghaus, R., Dressman, J. B., & Lippert, J. (2011) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.22726 · Cited by 139
Davies, M., Jones, R. D. O., Grime, K., Jansson-Löfmark, R., Fretland, A. J., Winiwarter, S., Morgan, P., & McGinnity, D. F. (2020) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2020.03.004 · Cited by 123
Jones, H. M., Gardner, I. B., Collard, W. T., Stanley, P. J., Oxley, P., Hosea, N. A., Plowchalk, D., Gernhardt, S., Lin, J., Dickins, M., et al. (2011) · Clinical Pharmacokinetics · doi:10.2165/11539680-000000000-00000 · Cited by 110
Evaluation of the GastroPlus™ Advanced Compartmental and Transit (ACAT) Model in Early Discovery
Gobeau, N., Stringer, R., De Buck, S., Tuntland, T., & Faller, B. (2016) · Pharmaceutical Research · doi:10.1007/s11095-016-1951-z · Cited by 67
Poulin, P., Hop, C. E. C. A., Ho, Q., Halladay, J. S., Haddad, S., & Kenny, J. R. (2012) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.23288 · Cited by 64
Berezhkovskiy, L. M. (2011) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.22324 · Cited by 63
Ferl, G. Z., Theil, F., & Wong, H. (2016) · Biopharmaceutics & Drug Disposition · doi:10.1002/bdd.1994 · Cited by 54
Darwich, A. S., Margolskee, A., Pepin, X., Aarons, L., Galetin, A., Rostami-Hodjegan, A., Carlert, S., Hammarberg, M., Hilgendorf, C., Johansson, P., et al. (2017) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2016.09.037 · Cited by 45
Hansmann, S., Darwich, A., Margolskee, A., Aarons, L., & Dressman, J. (2016) · Journal of Pharmacy and Pharmacology · doi:10.1111/jphp.12618 · Cited by 38
Assmus, F., Houston, J. B., & Galetin, A. (2017) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2017.08.014 · Cited by 36
Tissue lipids and drug distribution: Dog versus rat
Rodgers, T., Jones, H. M., & Rowland, M. (2012) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.23285 · Cited by 31
Self-citationXia, B., Heimbach, T., Lin, T.-H., He, H., Wang, Y., & Tan, E. (2012) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-012-1863-5 · Cited by 23
Samant, T., Lukacova, V, & Schmidt, S. (2017) · CPT: Pharmacometrics & Systems Pharmacology · doi:10.1002/psp4.12180 · Cited by 22
Predicting Food–Drug Interactions between Piperine and CYP3A4 Substrate Drugs Using PBPK Modeling
Lin, F., Hu, Y., Zhang, Y., Zhao, L., Zhong, D., & Liu, J. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms252010955 · Cited by 20
Schmitt, M. V., Reichel, A., Liu, X., Fricker, G., & Lienau, P. (2021) · Drug Metabolism and Disposition · doi:10.1124/dmd.120.000161 · Cited by 19
Korzekwa, K., & Nagar, S. (2017) · Pharmaceutical Research · doi:10.1007/s11095-016-2089-8 · Cited by 18
Sayama, H., Komura, H., Kogayu, M., & Iwaki, M. (2013) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.23726 · Cited by 16
Parameterization of small intestinal water volume using PBPK modeling
Maharaj, A., Fotaki, N., & Edginton, A. (2015) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2014.10.016 · Cited by 10
Metadata
- Authors
- Rodgers, T., & Rowland, M.
- Venue
- Journal of Pharmaceutical Sciences
- Publisher
- Elsevier BV
- Published
- 2006-06
- Volume
- 95
- Issue
- 6
- Pages
- 1238-1257
- ISSN
- 0022-3549 (ISSN-L)
- OpenAlex
- W2113830209
- Cited by
- 946
- References
- 45
- FWCI
- 16.06
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.